BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• 

  Genetown

  This is Why Biogen’s Stock is Set to Soar in 2017

  December 21, 2016

   · 

  2 min read
• Policy

  Advanced Accelerator Applications Receives Complete Response Letter From FDA For Lutathera, An Investigational Treatment For Neuroendocrine Tumors

  December 21, 2016

   · 

  6 min read
• Drug Development

  Unexpected Clinical Results Cause Hansa Medical to Terminate Phase II With IdeS in Acquired TTP

  December 21, 2016

   · 

  2 min read
• Business

  Exelixis And Ipsen Amend Exclusive Licensing Agreement For The Commercialization And Development Of Cabozantinib To Include Canada

  December 21, 2016

   · 

  13 min read
• Drug Development

  After Failed Phase III, Auven to Terminate the KIACTA Program

  December 21, 2016

   · 

  6 min read
• Business

  Takeda Makes €10 Million Equity Investment In TiGenix

  December 21, 2016

   · 

  3 min read
• Deals

  Novartis AG Buys TECH Fort Worth Client Encore Vision

  December 21, 2016

   · 

  3 min read
• Deals

  Shanghai’s Harbour Biomed Raises $50 Million; Acquires Discovery Company

  December 21, 2016

   · 

  1 min read
• Business

  Bracket Welcomes Clinical Vice President Lewis Fredane, MD To Global Team

  December 21, 2016

   · 

  1 min read
• Business

  Craig Martin Joins Fibrolamellar Cancer Foundation Board

  December 21, 2016

   · 

  3 min read